Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. News/
  3. Innovation/
  4. Nod™: The digital coach designed to help your baby sleep better
Nod Mom-Baby video capture

Nod™: The digital coach designed to help your baby sleep better

Is your little one keeping you up at night? This new app could help answer some of your late-night “I need more sleep!” prayers.

It’s a question that has mystified new parents since the dawn of time: “How in the world do I get this child to go to sleep?”
Thanks to novel 21st-century technology—and a partnership between Johnson & Johnson Consumer Inc. and Rest Devices, Inc., makers of the Mimo™ Baby Monitor—the answer (and those much-needed Zzzzs) could now be far less elusive.

It’s a collaboration that marries technology and expert coaching from JOHNSON’S® BEDTIME® Baby Sleep App with analytics from Mimo™'s infant sleep wearables and crib monitors to produce a new app called Nod™.

The goal: Both companies have studied hundreds of thousands of baby sleep patterns, so by combining their expertise, the Nod™ app can provide parents with an advanced, personalized sleep coaching system—like having a baby sleep expert in your own home.

The app debuts at the Consumer Electronics Show in Las Vegas this week. In anticipation, we tapped Russel Walters, Research Fellow of Biophysics and Modeling at Johnson & Johnson; sleep expert Jodi Mindell, Ph.D., CBSM; and Dulcie Madden, Co-founder and CEO of Rest Devices, Inc., to walk us through the groundbreaking technology.

1775614113001-5270880003001-5270841823001-vs.jpg
nod_3_ƒ

More from Johnson & Johnson

Could we be on our way to eliminating cancer for good?

What once seemed like an unattainable goal may soon be within our grasp. Learn how Johnson & Johnson is working toward its vision to create a world without cancer.

What’s the difference between IBS and IBD?

These GI conditions sound similar, and they also share some symptoms. But IBS and IBD are distinct disorders—especially when it comes to treatment and the risk of complications.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.